|Bid||159.10 x 100|
|Ask||159.17 x 100|
|Day's Range||157.25 - 161.76|
|52 Week Range||71.46 - 167.00|
|PE Ratio (TTM)||221.92|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
New trial data for cystic fibrosis drug cocktails boost its sales outlook.
It's well-known that technology stocks are leading the advance in the S&P 500, but health care stocks are close behind.
Vertex Pharmaceuticals research results ignited a strong biotech sector advance that could gain traction in coming weeks.